Sign in
4

Changes in Ownership

Sarepta Therapeutics, Inc. Filed Acc 0001209191-18-017794

Options or other derivatives

  • SVP, Chief Regulatory Affairs acquired 70,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Ruff Shamim · SVP, Chief Regulatory Affairs

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2018-03-05 Grant or award : show line 1 in the form Stock option (right to buy) +70,000 $71.45 2028-03-05 70,000 70,000 D
Loading xslF345X03/doc4.xml…